In this interview with Plastic Surgery Practice , Joely Kaufman, MD, a board-certified dermatologist, fellow of the American Academy of Dermatology, and director of Skin Associates of South Florida in Coral Gables, discusses findings from the study, Survey of Facial Aesthetic Concerns and Treatment Trends Following GLP-1 Agonist-Associated Weight Loss , presented at the 2025 American Society for Dermatologic Surgery Annual Meeting, and shares how plastic surgeons and other aesthetic providers are adapting their treatment algorithms to address the unique facial changes associated with GLP-1related weight loss
Our findingslower VTE risk versus DPP-4i and neutrality in head-to-head comparisonsare consistent with this perspective and with the hypothesis of a prothrombotic milieu in diabetes that does not consistently translate into large clinical effects [8, 14]
We look at your medical history, talk about your goals, and decide together if its a good fit
3b) and NP2 had an average hydrodynamic diameter of 116 nm and a PDI of 0.07 (Supplementary Fig
Pharmacol Res 186:106550
Licensed Compounding Sources We source exclusively from FDA-regulated compounding pharmacies meeting USP sterility standards
